Abstract:Purpose: To develop and evaluate the diagnostic ability of MRI image deep features and radiomics features between normal controls and Parkinson's disease (PD).Methods: MRI T1-weighted images diagnosed with PD from four Centers were collected, with sample sizes of 401,421,43 and 40. Clinical factors including age, gender, U3, H-Y stage and MMSE were statistically analyzed. 2D deep, 3D deep and radiomics features of MRI images were extracted by 2D-Resnet50, 3D-Resnet50 and Pyradiomic respectively. The classification models were trained and tested internally in Center 1 and tested externally in Center 2,3,4. The correlation between clinical and image features was analyzed, and CAM was used to explain the activation area of deep learning and visualized. Finally, independent factors were obtained from the above features to construct a Nomogram, and features’ contributions were quantified, and the AUCs, calibration and DCA curves were obtained.Results: There were significant differences between PD and NC in five clinical factors(p <0.05). The AUCs of 2D deep and 3D deep features in internal training set (Centre1) were 0.9062 and 0.8426, in internal test set (Centre1) were 0.8096 and 0.6880, well in external test set (Centre2: 0.7948 and 0.7649, Centre3: 0.7292 and 0.6111, Centre4: 0.7525 and 0.6075) . LR-radiomics classifier’s AUC performed well in internal training ( 0.8651) and internal test set (0.8335), and verified satisfactory AUC in three external test sets (Centre2: 0.7885, Centre3:0.6181, Centre4:0.74). A Nomogram was constructed and has the best AUC in internal training set (0.9437) and internal test set (0.8501), and was significantly higher than other single feature models (P <0.05), and showed the highest F1-score and the lowest FPR and FNR.Conclusion: This study demonstrated the effectiveness of brain MRI image features in rapid adjunctive diagnosis of PD and had the potential to contribute to early control of PD.Funding Information: This work was supported by the National Natural Science Foundation of China (Grant Nos. 82171888, 82001767, and 81971577), the Natural Science Foundation of Zhejiang Province (Grant No. LY22H180002 and LQ21H180008), the China Postdoctoral Science Foundation (Grant Nos. 2021T140599 and 2019M662082), and the 13th Five-year Plan for National Key Research and Development Program of China (Grant No. 2016YFC1306600). Declaration of Interests: All authors declare no competing interests.Ethics Approval Statement: All patients with PD and normal controls signed informed consent forms in accordance with the approval of the Medical Ethic Committee of the Second Affiliated Hospital of Zhejiang University School of Medicine (Nos.2012-26 and 2017-008).

Multivariate radiomics models based on 18F-FDG hybrid PET/MRI for distinguishing between Parkinson's disease and multiple system atrophy

A Multiple-Tissue-specific Magnetic Resonance Imaging Model for Diagnosing Parkinson's Disease: a Brain Radiomics Study.

Contribution and Clinical Significance of 3D and 2D Deep Learning and Radimoics Features Based on MR-T1W Images in Joint Diagnosis of Parkinson's Disease

An Automated Hybrid Approach Via Deep Learning and Radiomics Focused on the Midbrain and Substantia Nigra to Detect Early-Stage Parkinson’s Disease

Multi-parametric radiomics of conventional T1 weighted and susceptibility-weighted imaging for differential diagnosis of idiopathic Parkinson's disease and multiple system atrophy

Joint Radiomics and Spatial Distribution Model for MRI-based Discrimination of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin-Oligodendrocyte-glycoprotein-igg-associated Disorder.

Identification of Parkinson's disease and multiple system atrophy using multimodal PET/MRI radiomics

Predicting the progression of Parkinson's disease using conventional MRI and machine learning: An application of radiomic biomarkers in whole-brain white matter

Application of combining 18F-FDG PET imaging and radiomics in the diagnosis of Parkinson′s disease and atypical parkinsonian syndromes

Use of radiomic features and support vector machine to distinguish Parkinson's disease cases from normal controls

Substantia Nigra Radiomics Feature Extraction of Parkinson’s Disease Based on Magnitude Images of Susceptibility-Weighted Imaging

A Radiomics Approach to Predicting Parkinson’s Disease by Incorporating Whole-Brain Functional Activity and Gray Matter Structure

A New Hybrid Method for Differential Diagnosis of Parkinsonism.

An Integrative Nomogram for Identifying Early-Stage Parkinson's Disease Using Non-motor Symptoms and White Matter-Based Radiomics Biomarkers from Whole-Brain MRI

Multiparametric hippocampal signatures for early diagnosis of Alzheimer's disease using 18F-FDG PET/MRI Radiomics

Automatic Classification of MSA Subtypes using Whole-brain Gray Matter Function and Structure-Based Radiomics Approach

Differentiating Parkinson's disease motor subtypes: A radiomics analysis based on deep gray nuclear lesion and white matter

Multi-modality radiomics of conventional T1 weighted and diffusion tensor imaging for differentiating Parkinson's disease motor subtypes in early-stages

Development and Validation of a Novel Model Incorporating MRI-based Radiomics Signature with Clinical Biomarkers for Distinguishing Pancreatic Carcinoma from Mass-Forming Chronic Pancreatitis.

Use of deep learning-based radiomics to differentiate Parkinson’s disease patients from normal controls: a study based on [ 18 F]FDG PET imaging

Radiomics Model Based on MR Images to Discriminate Pancreatic Ductal Adenocarcinoma and Mass-Forming Chronic Pancreatitis Lesions